Life Sciences South West – going for growth
27 March 2019
For the first time Life Sciences has been properly recognised locally as an enabler of growth. This could mean more opportunities for employment for University of Bristol students and more potential for research collaborations with partners benefitting from the close proximity. Richard Seabrook, Elizabeth Blackwell Institute’s Advisor on Business Development, explains what’s next for the strategy to deliver long-term growth for the Life Sciences sector in the South West.
Following the successful EBI collaboration with GW4 to achieve recognition for life and health sciences innovation in Bristol and the West of England for the re launched UK Industrial Strategy Life Science Sector Deal we are now working alongside partners such as Invest Bristol and Bath, Bristol Health Partners and UWE, on the West of England Combined Authority local Industrial Strategy, due to be finalised September 2019.
The process led by WECA commenced in October 2018 and the evidence base we have been contributing to was published in February this year. We are delighted that Life Sciences is now properly recognised locally alongside more established Medtech and Digital Health, Robotics, Finntech, Creative Digital and others.
The next phase of strategy development is centred on two overriding objectives:
- to deliver long-term growth that is inclusive and clean and
- to accelerate economic growth by strengthening productivity to ensure that the region creates high-quality, well-paid jobs for our residents.
The evidence to date is showing an emerging sector:
- 1288 jobs were advertised in the Life Sciences sector in the West of England between January 2018 and December 2018
- The demand for jobs in Bristol was the same as the UK average for Life Sciences jobs
- The demand for jobs in Bath and Weston-Super-Mare was much lower than the UK average
- The mean salary of advertised jobs was £33,800
- 2700 employees across the sector
- Academic research base employs 1560 people
- 900 people at the University of Bristol
- 540 people at the University of Bath
- 120 people at the University of the West of England
BriSynBio, a BBSRC/EPSRC funded Synthetic Biology Research Centre at the University of Bristol, is especially noted as an engine of growth having nurtured the translation of research into four companies (Zentraxa, Cytoseek, Imophoron, and Alpha Nanopore) with a further two in the pipeline.
Over the coming months we will be contributing further to WECA’s strategy development. Life and Health Sciences can make an exciting and meaningful contribution to the objectives of inclusive and clean economic growth for the benefit of the region.
We are building links between our research community and partners in the business sector; providing support to establish and sustain strategic partnerships with business to both advance science and deliver benefits to society.
We would be pleased to hear from you if you wish to discuss partnerships.
Richard Seabrook’s role at the Elizabeth Blackwell Institute is to support University of Bristol researchers to enhance their engagement with life and health science business and to optimise their research plans to improve the attraction for business and potential for translational impact.
Get in touch with us to find out how you could benefit from a partnership between business and the University of Bristol, email: Richard Seabrook
University of Bristol are proud members of BIA, the UK Bioindustry Association
Elizabeth Blackwell Institute supports University of Bristol Business Champions in faculties. For more information contact Elizabeth Blackwell Institute Manager, Nina Couzin.
Find out more about how Elizabeth Blackwell Institute is building links with business.